Las muertes por causas aceptables.

Same author

An anti-rickettsial antibiotic from a streptomycete, M-4209. I. Biological characterizations.

Antibiotics & chemotherapy (Northfield, Ill.)·2014

Same author

On some biological characteristics of streptomycin B.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Same author

Antibacterial lipids from Tetrahymena geleii.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Same author

Serum levels and excretion studies in mice following injection of a penicillin-albumin complex.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010

Same author

Prophylactic aspirin use in the adult general population.

Journal of public health medicine·2004

Same author

Imatinib for chronic myeloid leukaemia: a NICE mess.

Lancet (London, England)·2001

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Las muertes por causas aceptables.

Videos de Conceptos Relacionados

An anti-rickettsial antibiotic from a streptomycete, M-4209. I. Biological characterizations.

On some biological characteristics of streptomycin B.

Antibacterial lipids from Tetrahymena geleii.

Serum levels and excretion studies in mice following injection of a penicillin-albumin complex.

Prophylactic aspirin use in the adult general population.

Imatinib for chronic myeloid leukaemia: a NICE mess.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Las muertes por causas aceptables.

Videos de Conceptos Relacionados

Artículos Relacionados

An anti-rickettsial antibiotic from a streptomycete, M-4209. I. Biological characterizations.

On some biological characteristics of streptomycin B.

Antibacterial lipids from Tetrahymena geleii.

Serum levels and excretion studies in mice following injection of a penicillin-albumin complex.

Prophylactic aspirin use in the adult general population.

Imatinib for chronic myeloid leukaemia: a NICE mess.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.